20 years of stemness: From stem cells to hypertranscription and back

被引:0
|
作者
Kim, Yun-Kyo [1 ,3 ]
Ramalho-Santos, Miguel [2 ,3 ]
机构
[1] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 0A4, Canada
[2] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5T 3L9, Canada
[3] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1X5, Canada
来源
STEM CELL REPORTS | 2025年 / 20卷 / 03期
关键词
SELF-RENEWAL; HEMATOPOIETIC STEM; RNAI SCREEN; GENE-EXPRESSION; HIPPO PATHWAY; STEM/PROGENITOR CELLS; TRANSCRIPTION; MOUSE; PLURIPOTENCY; CHROMATIN;
D O I
10.1016/j.stemcr.2025.102406
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Transcriptional profiling of stem cells came of age at the beginning of the century with the use of microarrays to analyze cell populations in bulk. Since then, stem cell transcriptomics has become increasingly sophisticated, notably with the recent widespread use of single-cell RNA sequencing. Here, we provide a perspective on how an early signature of genes upregulated in embryonic and adult stem cells, identified using microarrays over 20 years ago, serendipitously led to the recent discovery that stem/progenitor cells across organs are in a state of hypertranscription, a global elevation of the transcriptome. Looking back, we find that the 2002 stemness signature is a robust marker of stem cell hypertranscription, even though it was developed well before it was known what hypertranscription meant or how to detect it. We anticipate that studies of stem cell hypertranscription will be rich in novel insights in physiological and disease contexts for years to come.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Clinical pharmacy: Looking 20 years back ... Looking 20 years forward
    Angaran, DM
    Bonal, J
    Eide, G
    Koda-Kimble, MA
    Lake, KD
    Leufkens, HGM
    PHARMACOTHERAPY, 2000, 20 (10): : 235S - 242S
  • [32] 30 years: from IVF to stem cells
    Deech, Ruth
    NATURE, 2008, 454 (7202) : 280 - 281
  • [33] 30 years: from IVF to stem cells
    Ruth Deech
    Nature, 2008, 454 : 280 - 281
  • [34] Control of Stemness by Fibroblast Growth Factor Signaling in Stem Cells and Cancer Stem Cells
    Gotoh, Noriko
    CURRENT STEM CELL RESEARCH & THERAPY, 2009, 4 (01) : 9 - 15
  • [35] Chd1 protects genome integrity at promoters to sustain hypertranscription in embryonic stem cells
    Aydan Bulut-Karslioglu
    Hu Jin
    Yun-Kyo Kim
    Brandon Cho
    Marcela Guzman-Ayala
    Andrew J. K. Williamson
    Miroslav Hejna
    Maximilian Stötzel
    Anthony D. Whetton
    Jun S. Song
    Miguel Ramalho-Santos
    Nature Communications, 12
  • [36] Characlerisation of early stemness regulation in teratocarcinoma stem cells
    Gallagher, M. F.
    Elbaruni, S.
    Heffron, C. C. B. B.
    Guenther, S. M.
    Henfrey, R.
    Martin, C.
    Sheils, O.
    O'Leary, J. J.
    LABORATORY INVESTIGATION, 2008, 88 : 327A - 327A
  • [37] MicroRNAs in Cancer Stem Cells: New Regulators of Stemness
    Xing, Fei
    Wu, Kerui
    Watabe, Kounosuke
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (33) : 5319 - 5327
  • [38] Overview of Cancer Stem Cells and Stemness for Community Oncologists
    Lathia, Justin D.
    Liu, Huiping
    TARGETED ONCOLOGY, 2017, 12 (04) : 387 - 399
  • [39] Erratum: Girdin maintains the stemness of glioblastoma stem cells
    A Natsume
    T Kato
    S Kinjo
    A Enomoto
    H Toda
    S Shimato
    F Ohka
    K Motomura
    Y Kondo
    T Miyata
    M Takahashi
    T Wakabayashi
    Oncogene, 2017, 36 : 3796 - 3796
  • [40] Overview of Cancer Stem Cells and Stemness for Community Oncologists
    Justin D. Lathia
    Huiping Liu
    Targeted Oncology, 2017, 12 : 387 - 399